Immunotherapy in Prostate Cancer

被引：1
|
作者：
Bolat, Deniz [1 ,3 ]
Haydaroyu, Ayfer [2 ,3 ]
机构：
[1] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Clin Urol, Izmir, Turkey
[2] Ege Univ, Dept Radiat Oncol, Fac Med, Izmir, Turkey
[3] Ege Univ, Inst Hlth Sci, Dept Basic Oncol, Izmir, Turkey
来源：
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2019年 / 18卷 / 02期
关键词：
Prostate cancer; immunotherapy; vaccine; checkpoint blockers; survival; PHASE-III TRIAL; SIPULEUCEL-T; ANDROGEN DEPRIVATION; CTLA-4; BLOCKADE; DOSE-ESCALATION; PD-1; DOUBLE-BLIND; SURVIVAL; VACCINE; CHEMOTHERAPY;
D O I：
10.4274/uob.galenos.2018.1142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In recent years, immunotherapy has become an important treatment alternative in the treatment of many cancers. Research on immunotherapy in prostate cancer has been accelerated by obtaining Food and Drug Administration (FDA) approval of sipuleucel-T for asymptomatic or minimal symptomatic metastatic castration-resistant prostate cancer (CRPC). Despite all these developments, the patients in whom these agents should be used, sequential use and combination strategies remain unclear. In this review, mechanisms of action and survival outcomes of different immunotherapeutic agents and therapeutic cancer vaccines in mCRPC are discussed.
引用
收藏
页码：67 / 72
页数：6
相关论文
共 50 条
  • [31] Immunotherapy for the treatment of prostate cancer
    Di Lorenzo, Giuseppe
    Buonerba, Carlo
    Kantoff, Philip W.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (09) : 551 - 561
  • [32] The potential for prostate cancer immunotherapy
    Rini, BI
    Small, EJ
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 46 : S117 - S125
  • [33] Immunotherapy for lethal prostate cancer
    Rescigno, Pasquale
    de Bono, Johann S.
    NATURE REVIEWS UROLOGY, 2019, 16 (02) : 69 - 70
  • [34] IMMUNOTHERAPY FOR ADVANCED PROSTATE CANCER
    Kantoff, P. W.
    ANNALS OF ONCOLOGY, 2012, 23 : 38 - 38
  • [35] Immunotherapy in metastatic prostate cancer
    Slovin, Susan F.
    INDIAN JOURNAL OF UROLOGY, 2016, 32 (04) : 271 - 276
  • [36] Immunotherapy for prostate cancer.
    Rini B.I.
    Small E.J.
    Current Oncology Reports, 2001, 3 (5) : 418 - 423
  • [37] Immunotherapy for metastatic prostate cancer
    Drake, Charles G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (04) : 438 - 444
  • [38] A Perspective of Immunotherapy for Prostate Cancer
    Silvestri, Ida
    Cattarino, Susanna
    Giantulli, Sabrina
    Nazzari, Cristina
    Collalti, Giulia
    Sciarra, Alessandro
    CANCERS, 2016, 8 (07)
  • [39] Advances in prostate cancer immunotherapy
    Havranek, EG
    Whelan, MA
    Greenhalgh, R
    Dalgleish, AG
    Pandha, H
    SURGICAL ONCOLOGY-OXFORD, 2002, 11 (1-2): : 35 - 45
  • [40] IMMUNOTHERAPY A vaccine for prostate cancer?
    Flemming, Alexandra
    NATURE REVIEWS CANCER, 2011, 11 (08) : 540 - 540
12345